The Global Asthma Therapeutics Market has been projected to grow at the CAGR of 2.5 % market during 2017-2025. In 2016, the market has generated the revenue of $ 19,534.01 million and is expected to reach up to $ 24,572.31 million in terms of revenue by 2025.
Asthma is a chronic respiratory disease mainly resulting from lower respiratory tract infection; its disease etiology is characterized by wheezing, coughing, breathlessness, and chest tightness. Causative agent for asthma can be genetic or environmental factors. There is no cure for asthma; however, it can be controlled and managed by using different medications.
Market Segment Insights
The global asthma therapeutics market is majorly segmented into drug classes such as bronchodilators and anti-inflammatories, and combination therapy. Products segment comprises dry powder inhalers, metered dose inhalers (MDIs), mist inhaler and nebulizers. In terms of route of administration, this market is further sub-segmented as inhalation, oral and parenteral drugs. Combination therapy held the largest market share in the drug class segment due to factors such as rising prevalence of asthma and patient compliance. Metered dose inhalers lead the product segment due to factors such as immediate relief in asthma attack and consistent drug delivery. Inhalation segment dominated the market in terms of route of administration due to factors such as faster onset of action, better pharmacodynamics and pharmacokinetic results achieved in asthma treatment.
North America, Latin America, Europe, Middle East and Africa and Asia Pacific, markets together form the major regional markets for asthma therapeutics. These regional markets are further sub-segmented into country specific markets on the basis of demand and market growth of asthma therapeutics. Among the considered regional markets, North America currently dominates the global asthma therapeutics market, with United States being the largest county-level market due to increase in number of patients suffering with asthma, early disease diagnosis and treatment, and supportive reimbursement policies. On the other hand, Asia Pacific is anticipated to be the fastest growing market for asthma therapeutics due to huge population base suffering with asthma, rapid industrialization causing increasing air pollution and high disposable income.
Market Competition Assessment:
Key players in the global asthma therapeutics market are Abbott Laboratories, AstraZeneca, Becton, Dickinson and Company, Boehringer Ingelheim GmbH, Chiesi Farmaceutici, F. Hoffmann-La Roche, GlaxoSmithKline Plc., Merck& Co., Inc., Pfizer, Philips Healthcare, Sanofi-Aventis SA, Sunovion Pharmaceuticals, Inc., Teva Pharmaceutical Industries Ltd. and others.
Chapter 1 Preface
1.1 Report Description
1.1.1 Purpose of the Report
1.1.2 Target Audience
1.1.3 USP and Key Offerings
1.2 Research Scope
1.3 Research Methodology
1.3.1 Phase I – Secondary Research
1.3.2 Phase II – Primary Research
1.3.3 Phase III – Expert Panel Review
Chapter 2 Executive Summary
2.1. Global Asthma Therapeutics Market Snapshot
2.2. Global Asthma Therapeutics Market, by Drug Class, 2016 ($ Million)
2.3. Global Asthma Therapeutics Market, by Product Type, 2016 ($ Million)
2.4. Global Asthma Therapeutics Market, by Route of Administration, 2016 ($ Million)
2.5. Global Asthma Therapeutics Market, by Geography, 2015 (Value %)
Chapter 3 Global Asthma Therapeutics Market Analysis
3.1. Global Asthma Therapeutics Market Overview
3.2. Market Dynamics
3.2.1. Market Drivers
3.3. Attractive Investment Proposition, 2016
3.4. Competitive Landscape Assessment, by Key Market Players
Chapter 4 Global Asthma Therapeutics Market, by Drug Class, 2015 – 2025 ($ Million)
4.2. Anti-inflammatory Drugs
4.4. Combination Therapy
Chapter 5 Global Asthma Therapeutics Market, by Product Type, 2015 – 2025 ($ Million)
5.2. Dry Powder Inhalers
5.3. Metered Dose Inhalers
5.4. Mist Inhalers
Chapter 6 Global Asthma Therapeutics Market, by Route of Administration, 2015 – 2025 ($ Million)
Chapter 7 Global Asthma Therapeutics Market, by Geography, 2015-2025 ($ Million)
7.1. North America
7.2.3. Rest of Europe
7.3. Asia Pacific
7.3.3. Rest of Asia Pacific
7.4. Latin America
7.4.3. Rest of Latin America
7.5. Middle East and Africa
7.5.2. Rest of Middle East and Africa
Chapter 8 Company Profiles
8.1. Abbott Laboratories
8.3. Becton, Dickinson and Company
8.4. Boehringer Ingelheim GmbH
8.5. Chiesi Farmaceutici
8.6. F. Hoffmann-La Roche
8.7. GlaxoSmithKline Plc.
8.8. Merck& Co., Inc.
8.10. Philips Healthcare
8.11. Sanofi-Aventis SA
8.12. Sunovion Pharmaceuticals, Inc.
8.13. Teva Pharmaceutical Industries Ltd.